Table 2 Longitudinal analysis results for the Cerumenogram investigation of a volunteer self-declared as part of the oncological risk-free group but classified as part of the oncological risk group.
From: Cerumenogram as an assay for the metabolic diagnosis of precancer, cancer, and cancer remission
Sample collection number | Event (date) | Predicted group | Actions |
|---|---|---|---|
I | First Cerumen Analysis (Patient Self-declared as Part of the Oncological Risk-free group) (October 25, 2019) | Oncological Risk | Proof Analysis Required |
II | Second Cerumen Analysis (Proof) (November 20, 2019) | Oncological Risk | Investigation of Biological Bias (Hypothesis of a Potential Biological Bias due to the Chronic Sinusitis Condition of the Volunteer |
III | Cerumen Analysis After Treatment for Chronic Sinusitis (December 12, 2019) | Oncological Risk | Investigation of Chronic Sinusitis influence on the Results (Hypothesis testing) |
IV | Fourth Cerumen Analysis for Patient Follow-up (February 06, 2020) | Oncological Risk | Volunteer Follow-up |
V | Cerumen Analysis During the Preoperative Procedures (June 03, 2020) | Oncological Risk | Cerumenogram Test Before the Operative Procedures |
VI | Cerumen, Tissue, and Sphenoid Sinuses Secretion Analysis (Surgery Day) (August 31, 2020) | Oncological Risk | Cerumenogram Test at the Endoscopic Sinus Surgery Day |
VII | Last Cerumen Analysis of the Volunteer before the 18F-FDG PET/CT examination (December 03, 2020) | Oncological Risk | Follow-up after the surgical procedure and imaging diagnostic indication |
